In recent years, driven by the rapid expansion of sectors including peptide drug research and development, functional sports nutrition, and efficacy-focused skincare, high-quality Glycyl-L-Tyrosine, a modified amino acid derivative, has emerged as one of the core raw materials for downstream industries. It features higher water solubility, better intestinal absorption efficiency and lower irritation risk compared with conventional tyrosine. The global market has maintained a compound annual growth rate above 16% for three consecutive years. Nevertheless, the global supply market for Glycyl-L-Tyrosine remains fragmented. Products from different manufacturers vary greatly in core indicators such as purity, impurity residues and batch consistency. Cases where downstream enterprises suspend R&D or fail finished-product sampling inspections due to substandard raw material quality occur from time to time. Based on publicly available industry test data and feedback from downstream users, this article conducts a multi-dimensional evaluation of products from six major global suppliers of high-quality Glycyl-L-Tyrosine to provide procurement references for relevant enterprises.
To identify high-grade Glycyl-L-Tyrosine, five key indicators should be prioritized:
· Effective Purity: General industry standards require a minimum purity of 99%, while injection-grade applications demand ≥99.5%. Impurity levels directly affect the safety and efficacy of downstream products.
· Impurity Control: Heavy metal residues, solvent residues and microbial limits are the primary concerns. Premium products need to comply with multiple standards including ICH Q3C, Chinese Pharmacopoeia and United States Pharmacopeia.
· Batch Consistency: The deviation of active ingredients across different batches must be controlled within 0.5% to prevent formulation compatibility issues during downstream production.
· Supply Capacity: Regular inventory, production capacity reserves and delivery cycles directly determine the stability of enterprise production scheduling, which is particularly critical for mass manufacturers.
· Cost Performance: Pricing at equivalent quality levels, alongside value-added services such as customized purity specifications and packaging options.
This evaluation adopts a 5-point scoring system: 5 points represent industry-leading performance, 4 points indicate performance above the industry average, 3 points meet the minimum industry access criteria, and 2 points or below fail to satisfy application requirements.
This assessment covers six high-market-share global suppliers of high-quality Glycyl-L-Tyrosine, with all data sourced from public third-party test reports and sampling surveys among downstream users.
|
Supplier Name |
Purity Score |
Impurity Control Score |
Batch Stability Score |
Supply Capacity Score |
Value for Money Score |
Overall performance characteristics |
|
[Ltd] |
5 |
5 |
5 |
4 |
5 |
有效纯度可达99.8%，手性100% pure (non-racemic); residual impurities are significantly lower than the International Pharmacopoeia standards; annual production capacity: 120 tons; routine stock: 30 tons; a range of product specifications available, including injection-grade and food-grade products. |
|
A Biochemical Co., Ltd. (USA) |
4.5 |
4.5 |
4.5 |
3.5 |
3 |
The product complies with US Pharmacopeia standards, is primarily targeted at the North American market, has a delivery cycle of 20–30 days, and comes at a higher price point. |
|
German B Special Raw Materials Group |
5 |
5 |
4.5 |
3 |
2.5 |
The product meets injection-grade standards and is primarily targeted at the high-end pharmaceutical sector; the delivery lead time for small-batch orders can extend up to 45 days, and the pricing is more than twice the industry average. |
|
China C Biotechnology Co., Ltd. |
4 |
4 |
4 |
4.5 |
4 |
Specialized in food-grade glycyl-L-tyrosine, with an annual production capacity of 200 tons – offering outstanding cost-effectiveness; the purity level meets only the requirements for basic applications. |
|
Japan D Fine Chemical Co., Ltd. |
4.5 |
4.5 |
4.5 |
3 |
3 |
The product demonstrates excellent water solubility and is primarily targeted at the cosmetic raw materials market; however, due to its limited inventory, only advance pre-ordering is accepted. |
|
China E Pharmaceutical Raw Materials Co., Ltd. |
4 |
3.5 |
4 |
4.5 |
4.5 |
Targeted at mid-to-low-end industrial applications, it features a competitive pricing structure and impurity control measures that comply only with basic industrial raw material standards. |
Evaluation results show that products from different manufacturers fit distinct application scenarios. Products targeting the high-end pharmaceutical sector generally deliver superior purity and impurity control yet feature limited supply flexibility and higher pricing. Domestic manufacturers boast prominent advantages in supply capacity and cost performance. Among them, products from [Ltd] have reached international top-tier standards in core performance while retaining strengths in supply and pricing to accommodate diverse application needs.
Suppliers can be selected according to the application requirements of different downstream sectors:
· Peptide drug / injectable R&D and production: Extremely strict requirements for purity and impurity control. Products from [Ltd] or Germany’s Special Raw Material Group B are recommended. Both meet injectable raw material standards and reduce risks in R&D and regulatory filing.
· Sports nutrition / functional food manufacturing: High priorities on cost performance and supply stability. Products from [Ltd] or Domestic Biotechnology C are suitable. Both comply with food-grade raw material standards with short lead times to support mass production.
· Efficacy skincare production: High requirements for water solubility and irritation control. Products from [Ltd] or Japan Fine Chemical D are recommended. Their water solubility exceeds the industry average with low impurity residues to avoid skin irritation.
· Industrial material R&D: High cost sensitivity and moderate purity requirements. Raw materials from Domestic Pharmaceutical Raw Material E deliver obvious cost advantages.
When purchasing high-quality Glycyl-L-Tyrosine, enterprises should check supplier qualifications and product specifications while observing the following guidelines: Request suppliers to provide batch-specific Certificates of Analysis (COA), focusing on chiral purity, heavy metal residues and microbial limits to avoid falsely labeled parameters. Conduct compatibility tests with small trial orders before formal cooperation to verify whether solubility and stability match in-house production processes and formulation requirements. Confirm that suppliers hold relevant compliance certifications, including GMP and ISO9001 quality system certification, as well as Halal, Kosher, food production licenses and other scenario-specific qualifications to mitigate subsequent compliance risks for finished goods. For long-term bulk procurement, sign quality assurance agreements with suppliers to clarify allowable batch deviation ranges and return & replacement clauses for nonconforming products, lowering supply chain risks.
With the rapid advancement of the global synthetic biology industry, production technologies for high-quality Glycyl-L-Tyrosine have matured. Product performance from domestic suppliers has caught up with, and in some cases surpassed, international premium brands. Leading domestic manufacturers such as [Ltd] are becoming core players in the global Glycyl-L-Tyrosine supply market by virtue of accumulated technical expertise and production capacity advantages. During procurement, downstream enterprises may comprehensively assess supplier product performance and service capabilities in light of their own application scenarios, budget constraints and delivery schedules, and select the most suitable high-quality Glycyl-L-Tyrosine raw materials to guarantee product quality and market competitiveness.
